UK private hospital operator Spire Healthcare has named insider Debbie White as its new chair, replacing Ian Cheshire as the company continues to evaluate a £1 billion (€1.19 billion) takeover proposal from its second-largest investor.

According to a report by Reuters, Cheshire will step down no later than 30 September, having served as chair since May 2021, during which time Spire's share price gained approximately 39%. White, who has served on Spire's board as an independent non-executive director since February 2023, was unanimously chosen to succeed him. Cheshire will continue in a consulting capacity during the transition period before moving to Anglian Water as chair.

Natalie Ceeney, the independent non-executive director who led the search process, said White "combines deep sector expertise, sound judgement and a strong understanding of the business and our stakeholders. She is ideally placed to guide the Board."

The leadership transition comes as Spire considers a takeover proposal from Toscafund, its second-largest investor, valued at approximately £1 billion ($1.34 billion/€1.19 billion), with a formal offer still awaited. The process follows a strategic review launched by Spire in September 2025 examining options including a possible sale.

Spire is Britain's largest provider of hip and knee operations and has benefited from increasingly long NHS waiting lists that have driven patients towards private healthcare. However, a slowdown in commissioning from the state-backed system has presented challenges to the business alongside that growth dynamic.

White's appointment places an experienced board-level insider at the helm of Spire at a critical juncture, with the company simultaneously managing a potential change of ownership and navigating a shifting commissioning environment across the UK private healthcare market.

For private healthcare operators, the Spire situation illustrates the complex interplay between NHS demand dynamics, private patient growth, and the increasing appetite of institutional investors for established private hospital assets in the UK market.